Dr. Ayaka Nishikawa, Chief Director of Dermatology at Shonan Beauty Clinic, Presents Her Research Findings at the 51st Annual Meeting of the Japan Society of Medical Epilation

Strengthening the Safety and Quality Standards of Medical Hair Removal Through the Utilization of Nationwide Clinical Data

IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Dr. Ayaka Nishikawa, Chief Director of Dermatology at Shonan Beauty Clinic, presented her research findings at the 51st Annual Meeting of the Japan Society of Medical Epilation, held on March 1, 2026.

The Japan Society of Medical Epilation is a prestigious academic organization dedicated to the promotion of safe and effective hair removal techniques based on medical evidence, as well as the technical advancement of medical professionals in the field. At the 51st Annual Meeting, Dr. Nishikawa delivered a presentation titled “Laser Hair Removal Challenges in Chain Clinics: Management Leveraging Clinical and Operational Insights.”

In the field of aesthetic medicine, where laser hair removal remains in high demand, providing consistent quality and ensuring customer safety are paramount for medical institutions. In her presentation, Dr. Nishikawa discussed case studies aimed at maximizing treatment efficacy based on the extensive clinical data of Shonan Beauty Clinic’s nationwide network. She also detailed the educational systems implemented to minimize complication risks and explained management methods for standardizing advanced medical techniques across all staff members. Her insights aim to contribute to the sound development of the medical hair removal industry.

As technological innovation continues to advance in aesthetic healthcare, the importance of academic collaboration and the sharing of specialized knowledge beyond clinical practice is increasing. To meet diversifying customer needs, a broad perspective and flexible approach are essential alongside the introduction of cutting-edge technology. SBC Medical remains committed to advancing the safety, transparency, and sustainable value of aesthetic healthcare through academic presentations and active exchange with research institutions.

Overview of “The 51st Annual Meeting of the Japan Society of Medical Epilation”

Venue: TKP Garden City PREMIUM Sapporo Odori

Dates: March 1, 2026

Official Website: https://igaku-datumou-meeting.jp/2026/

Presentation Title

Laser Hair Removal Challenges in Chain Clinics: Management Leveraging Clinical and Operational Insights

About Dr. Ayaka Nishikawa

After graduating from the School of Medicine at Yokohama City University, Dr. Ayaka Nishikawa joined Shonan Beauty Clinic in 2015 as a dermatologist specializing in aesthetic medicine. In 2018, she was appointed Chief Director of Dermatology and currently oversees a wide range of initiatives across the SBC Medical Group, including the development of new dermatological treatments, technical training for doctors and nurses, and safety management. Through the analysis of clinical cases, she is dedicated to promoting evidence-based medical practice and actively engages in academic activities such as presenting at domestic and international conferences and contributing to medical journals. In recognition of her achievements, she was appointed Visiting Professor at SBC Tokyo Medical University in 2023. For more information on Dr. Nishikawa’s professional profile, please visit [here].

About SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/

For more insights and updates from SBC Holdings, follow us on LinkedIn　

Contacts

SBC Medical Group Holdings Incorporated

Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com

ICR LLC (US Time)

Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com